The use of immune modulator therapeutics, a type of immunotherapy enhancing the body immune system response to cancer, was perceived as the beginning of a new era in cancer care. While still important and frequently used, some of these therapeutics produce uneven response rates, disease resistance, and serious side effects. The National Academies National Cancer Policy Forum, in collaboration with the Forum on Drug Discovery, Development, and Translation, hosted a public workshop to discuss challenges related to immunotherapy treatment resistance, as well as potential policy opportunities to improve the development of immunotherapies for cancer treatment.
Cumpărați această carte electronică și primiți încă 1 GRATUIT!
Limba Engleză ● Format EPUB ● Pagini 86 ● ISBN 9780309716291 ● Editor Anne Frances Johnson & Erin Balogh ● Editura National Academies Press ● Publicat 2024 ● Descărcabil 3 ori ● Valută EUR ● ID 9995925 ● Protecție împotriva copiilor Adobe DRM
Necesită un cititor de ebook capabil de DRM